Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Treatment of Dry Eye With Miebo in Subjects Undergoing LASIK
NCT07650708Phase 4Recruiting
- Sponsor
- Vance Thompson Vision
- Start
- May 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of perfluorohexyloctane in dry eye disease (DED), sponsored by Vance Thompson Vision. Primary endpoint: Visual Analog Scale Eye Dryness Score at 4 months. Started May 2026; status: recruiting.
02
Drugs
perfluorohexyloctane
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT07650708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07650708.